- Home
- MRVI vs GSRT Comparison
MRVI vs GSRT Comparison
Compare MRVI & GSRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- GSRT
- Stock Information
- Founded
- MRVI 2014
- GSRT 2023
- Country
- MRVI United States
- GSRT United States
- Employees
- MRVI 560
- GSRT N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- GSRT
- Sector
- MRVI Health Care
- GSRT
- Exchange
- MRVI Nasdaq
- GSRT Nasdaq
- Market Cap
- MRVI 350.1M
- GSRT 302.2M
- IPO Year
- MRVI 2020
- GSRT 2024
- Fundamental
- Price
- MRVI $2.42
- GSRT $10.37
- Analyst Decision
- MRVI Hold
- GSRT Strong Buy
- Analyst Count
- MRVI 10
- GSRT 1
- Target Price
- MRVI $5.84
- GSRT $19.00
- AVG Volume (30 Days)
- MRVI 1.5M
- GSRT 518.2K
- Earning Date
- MRVI 08-11-2025
- GSRT 01-01-0001
- Dividend Yield
- MRVI N/A
- GSRT N/A
- EPS Growth
- MRVI N/A
- GSRT N/A
- EPS
- MRVI N/A
- GSRT 0.19
- Revenue
- MRVI $219,830,000.00
- GSRT N/A
- Revenue This Year
- MRVI N/A
- GSRT N/A
- Revenue Next Year
- MRVI $7.23
- GSRT N/A
- P/E Ratio
- MRVI N/A
- GSRT $53.45
- Revenue Growth
- MRVI N/A
- GSRT N/A
- 52 Week Low
- MRVI $1.67
- GSRT $9.86
- 52 Week High
- MRVI $9.60
- GSRT $11.49
- Technical
- Relative Strength Index (RSI)
- MRVI 49.60
- GSRT 40.74
- Support Level
- MRVI $2.28
- GSRT $10.36
- Resistance Level
- MRVI $2.47
- GSRT $10.40
- Average True Range (ATR)
- MRVI 0.14
- GSRT 0.08
- MACD
- MRVI -0.01
- GSRT 0.01
- Stochastic Oscillator
- MRVI 27.45
- GSRT 14.67
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About GSRT GSR III Acquisition Corp. Ordinary Shares
GSR III Acquisition Corp is a blank check company.